- Home
- FTF vs LSBPW Comparison
FTF vs LSBPW Comparison
Compare FTF & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTF
- LSBPW
- Stock Information
- Founded
- FTF 2003
- LSBPW N/A
- Country
- FTF United States
- LSBPW China
- Employees
- FTF N/A
- LSBPW 758
- Industry
- FTF Finance/Investors Services
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- FTF Finance
- LSBPW Health Care
- Exchange
- FTF Nasdaq
- LSBPW Nasdaq
- Market Cap
- FTF N/A
- LSBPW N/A
- IPO Year
- FTF N/A
- LSBPW N/A
- Fundamental
- Price
- FTF $6.66
- LSBPW $0.04
- Analyst Decision
- FTF
- LSBPW
- Analyst Count
- FTF 0
- LSBPW 0
- Target Price
- FTF N/A
- LSBPW N/A
- AVG Volume (30 Days)
- FTF 153.9K
- LSBPW N/A
- Earning Date
- FTF 01-01-0001
- LSBPW N/A
- Dividend Yield
- FTF 11.45%
- LSBPW N/A
- EPS Growth
- FTF N/A
- LSBPW N/A
- EPS
- FTF N/A
- LSBPW N/A
- Revenue
- FTF N/A
- LSBPW N/A
- Revenue This Year
- FTF N/A
- LSBPW N/A
- Revenue Next Year
- FTF N/A
- LSBPW N/A
- P/E Ratio
- FTF N/A
- LSBPW N/A
- Revenue Growth
- FTF N/A
- LSBPW N/A
- 52 Week Low
- FTF $5.76
- LSBPW N/A
- 52 Week High
- FTF $6.56
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- FTF 60.53
- LSBPW N/A
- Support Level
- FTF $6.51
- LSBPW N/A
- Resistance Level
- FTF $6.65
- LSBPW N/A
- Average True Range (ATR)
- FTF 0.07
- LSBPW 0.00
- MACD
- FTF 0.02
- LSBPW 0.00
- Stochastic Oscillator
- FTF 98.28
- LSBPW 0.00
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.